Multibic

Sodium hydrogen carbonate, the active ingredient in Multibic, is an electrolyte solution presented as a solution for injection for intravenous and haemodialysis use. It supplies sodium, chloride, calcium, magnesium ions and a bicarbonate buffer to maintain acid‑base and electrolyte balance during haemodialysis and intravenous electrolyte replacement. Multibic is classified as a renal replacement therapy adjunct and is used in hospitals and dialysis centres for patients requiring precise electrolyte management.

GNH USA supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and dialysis clinics worldwide.

Multibic is used as an electrolyte solution in renal replacement therapy and intravenous electrolyte replacement. - Haemodialysis fluid: provides balanced sodium, chloride, calcium, magnesium and bicarbonate to maintain acid‑base status during dialysis. - Intravenous electrolyte replacement: corrects deficits of key electrolytes in patients receiving IV therapy. - Renal replacement therapy adjunct: supports overall electrolyte homeostasis in patients undergoing dialysis procedures.

Multibic may cause electrolyte‑related reactions and infusion site responses.

Common Side Effects: - Hypernatremia: elevated serum sodium levels. - Hyperchloremia: increased chloride concentration. - Hypercalcemia: excess calcium in blood. - Hypermagnesemia: raised magnesium levels. - Infusion site irritation: redness or discomfort at injection site. - Fluid overload: excess extracellular fluid volume.

Serious or Rare Side Effects: - Severe electrolyte imbalance: potentially life‑threatening shifts. - Metabolic alkalosis: excessive bicarbonate leading to high pH. - Anaphylactic reaction: rare hypersensitivity response. - Cardiac arrhythmia: abnormal heart rhythm due to electrolyte disturbances. - Hypotension: sudden drop in blood pressure during rapid infusion. - Pulmonary edema: fluid accumulation in lungs from overload.

When using Multibic, clinicians should observe several safety measures. - Monitor serum electrolytes: regularly check sodium, chloride, calcium, and magnesium levels. - Adjust infusion rate: tailor to the patient’s fluid status and clinical response. - Use with caution in heart failure: risk of fluid overload. - Avoid in severe hypercalcemia or hypermagnesemia: may exacerbate toxicity. - Contraindicated in known hypersensitivity to any component. - Store at ambient temperature: keep in original container, protect from light and moisture.

Multibic can interact with other medicines that affect electrolyte balance.

Major Interactions (Avoid): - Concurrent calcium supplements: may cause hypercalcemia. - Additional bicarbonate solutions: risk of metabolic alkalosis. - High‑dose diuretics: can intensify electrolyte shifts. - Sodium‑rich medications: may lead to hypernatremia. - Magnesium‑containing antacids: increase risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor potassium and renal function. - Loop diuretics: watch for calcium loss. - NSAIDs: may affect renal clearance of electrolytes. - Beta‑blockers: observe blood pressure changes. - Anticoagulants used in dialysis: monitor for bleeding risk.